Norsk Hydro: Hydro and Agder Energi sign LoI to establish a

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Norsk Hydro: Hydro and Agder Energi sign LoI to establish a jointly owned company to develop Otra assets

OSLO, Norway, Sept. 27, 2013 (GLOBE NEWSWIRE) --

Hydro and Agder Energi have signed a Letter of Intent (LOI) for the possible establishment of a jointly owned company to operate and further develop their combined assets in the Otra River, southern Norway, where Hydro recently acquired the Vigelands Brug hydropower plant. The LoI is conditional on a proposed adjustment of the Industrial Concession Act to enable private entities the possibility to organize an ownership share in a company with liability (ANS/DA). This will enable private entities to take out profit in the form of power rather than restricting it to financial remuneration, which is important to Hydro as a fully integrated aluminium company active throughout the value chain from bauxite to finished products. Should it materialize, Hydro would own less than one-third of the envisaged jointly owned company (DA), which would satisfy the legal requirements regarding public control and be comparable to Hydro owning one-third in a private limited company. Hydro acquired the 180 GWh Vigelands Brug hydropower station on the lower Otra River in June, as part of a broader agreement with Rio Tinto Alcan to take over both the high-purity Vigeland Metal Refinery and the on-site "run-on-the-river" power station. Based in southern Norway, Agder Energi is Norway's fourth-largest power producer, with 47 fully owned and part-owned production assets - of which 10 are located on the Otra River. In addition, Hydro and Agder have signed an agreement regarding project management support. Hydro's Projects unit has provided project management resources and systems to Agder Energi since summer of 2012 to execute the Iveland 2 project. This cooperation has now been extended through a Collaboration Agreement to cover all of Agder Energi's major hydropower projects, lasting for several years. Investor contact Contact     Pål Kildemo Cellular    +47 97096711 E-mail      Pal.Kildemo@hydro.com Press contact Contact     Halvor Molland Cellular    +47 92979797 E-mail       Halvor.Molland@hydro.com ********* Certain statements included within this announcement contain forward looking information, including, without limitation, those relating to (a) forecasts, projections and estimates, (b) statements of management's plans, objectives and strategies for Hydro, such as planned expansions, investments or other projects, (c) targeted production volumes and costs, capacities or rates, start-up costs, cost reductions and profit objectives, (d) various expectations about future developments in Hydro's markets, particularly prices, supply and demand and competition, (e) results of operations, (f) margins, (g) growth rates, (h) risk management, as well as (i) statements preceded by "expected", "scheduled", "targeted", "planned", "proposed", "intended" or similar statements. Although we believe that the expectations reflected in such forward-looking statements are reasonable, these forward-looking statements are based on a number of assumptions and forecasts that, by their nature, involve risk and uncertainty. Various factors could cause our actual results to differ materially from those projected in a forward-looking statement or affect the extent which a particular projection is realized. Factors that could cause these differences include, but are not limited to: our continued ability to reposition and restructure our upstream and downstream aluminium business; changes in availability and cost of energy and raw materials; global supply and demand for aluminium and aluminium products; world economic growth, including rates of inflation and industrial production; changes in the relative value of currencies and the value of commodity contracts; trends in Hydro's key markets and competition; and legislative, regulatory and political factors. No assurance can be given that such expectations will prove to have been correct. Hydro disclaims any obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. This information is subject of the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act. [HUG#1731717]

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 3

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 3

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
NARUTO Card Game Set for June 2027 Global Launch

Updated Category News Views 8

Mark Your Calendars: Global Launch June 2027 They're rolling out a red carpet for nostalgia here, I tell ya! At the New York Comic Con, BANDAI announced a worldwide launch for the NARUTO CARD GAME in June 2027. We'll see pre-built decks starring your favorite shinobi and a mad sprint to collect with the new booster packs. Feels sort of like they’re summoning a jutsu...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 6

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 3

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
Phase I of 2026 Hong Kong Trade Shows Highlights Innovation

Updated Category News Views 7

Hong Kong Takes Center Stage in Global Commerce Flip through the economic landscape today, and you’ll spot Hong Kong, decked out in its best as a trade linchpin—with over 2,100 suppliers gathered under one roof. AsiaWorld-Expo is buzzing with the commencement of Phase I of the October 2026 Global Sources Hong Kong Shows. The theme's all about 'Connecting Global...

Continue Reading
AI Drives Major Time Savings in Endoscopy Tech

Updated Category News Views 9

AI in Endoscopy: Game-Changer or Gimmick? Stumbling across AnX Robotica's latest pitch about their NaviCam ProScan AI workflow, one can't help but feel a mix of curiosity and skepticism. With the stakes in medical tech sky-high, they've fired off some impressive stats that grab attention. We're talking about cutting small-bowel capsule review times by a whopping...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 6

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 9

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
Southern Company Sparks Swift Power Restoration Post-Isaias

Updated Category News Views 10

Well, when Mother Nature decides to throw a tantrum, it takes seasoned hands and savvy tech to clean up the mess. That's exactly what Southern Company is doing after Hurricane Isaias wreaked havoc on the Southeast. With their electric utilities—Alabama Power, Georgia Power, and Mississippi Power—hitting the ground running, they've already restored power to a whopping...

Continue Reading

Top 5 Most Recently Viewed Articles

Exploring the Growth of $100 Investment in TD Synnex - A 20-Year Review

Updated Category News Views 201

Understanding the Value of Long-Term Investments Investing can often feel daunting, but the story of TD Synnex (NYSE: SNX) illustrates the powerful potential of long-term commitment. Over the last two decades, the company's stock has outperformed the broader market, delivering compelling returns to its investors. The Journey of TD Synnex Over the Past 20 Years During this...

Continue Reading
Growth of Nuclear Medicine Software Market Expected to Surge

Updated Category News Views 101

Emerging Trends in the Nuclear Medicine Software Market The nuclear medicine software market is poised for significant growth, projected to reach approximately US$1,491.55 million by 2030. This represents a compound annual growth rate (CAGR) of 9.0% from its current valuation. As healthcare continues to evolve, the demand for precise and early diagnostics is paramount,...

Continue Reading
Quanterix Corporation Faces Investigation Amid Investor Concerns

Updated Category News Views 400

Quanterix Corporation Faces Scrutiny from Rosic Law Firm In a recent development, Quanterix Corporation (NASDAQ: QTRX) has come under investigation by the Rosen Law Firm. This esteemed global investor rights law firm is exploring potential securities claims on behalf of the company's shareholders. The investigation arises from allegations of misleading business...

Continue Reading
Navigating Market Dynamics: Strategies for Today's Investors

Updated Category News Views 139

Understanding Market Strategies To excel in today's stock market, it's essential to have a keen understanding of various investment strategies. The current landscape suggests that savvy investors can find profitable opportunities even amid volatility. Taking Advantage of Hedges In light of recent sell-offs, a prudent strategy involves taking partial profits on hedges....

Continue Reading
Celebrate the Magic of Middle-earth: A Unique Reunion Tour

Updated Category News Views 246

FAN EXPO Celebrates 25 Years of The Lord of the Rings FAN EXPO HQ is thrilled to announce a special celebration marking the 25th anniversary of the iconic film, The Lord of the Rings. This memorable event, titled An Evening with the Hobbits: In Celebration of 25 Years, will take place in 11 cities across North America, starting in January. Key cast members Elijah Wood,...

Continue Reading